Earnings Feed
Start Free
Home/Filings/4/0001573202-17-000006
4//SEC Filing

RespireRx Pharmaceuticals Inc. 4

Accession 0001573202-17-000006

CIK 0000849636operating
View on SEC.govCompany Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 11:13 AM ET

Size

11.9 KB

Accession

0001573202-17-000006

Insider Transaction Report

Form 4
Period: 2017-06-30
RespireRx Pharmaceuticals Inc.RSPI
Purcell Richard David Jr.
SVP - Research & Development
Transactions
  • Award

    Common Stock Options (to purchase shares of Common Stock)

    2017-06-30+40,000→ 40,000 total
    Exercise: $2.00Exp: 2022-06-30→ common stock (40,000 underlying)
Holdings

  • Common Stock Options (to purchase shares of Common Stock)

    Exercise: $3.90Exp: 2022-01-17→ common stock (40,000 underlying)
    40,000

  • Common Stock Options (to purchase shares of Common Stock)

    Exercise: $6.40Exp: 2022-08-18→ common stock (9,231 underlying)
    9,231

  • Common Stock Options (to purchase shares of Common Stock)

    Exercise: $7.38Exp: 2021-03-31→ common stock (61,539 underlying)
    61,539

  • Common Stock Options (to purchase shares of Common Stock)

    Exercise: $8.13Exp: 2022-06-30→ common stock (6,154 underlying)
    6,154
Footnotes (6)
  • [F1]These Common Stock Options vested upon issuance.
  • [F2]These Common Stock Options vested in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017, and are all currently vested.
  • [F3]The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
  • [F4]These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested.
  • [F5]These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested.
  • [F6]The Common Stock Options vested in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested.

Documents

1 file

Issuer

RespireRx Pharmaceuticals Inc.

CIK 0000849636

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000849636

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 11:13 AM ET
Size
11.9 KB
View on SEC.gov